Currently, TMEM161B‐AS1 has been verified to be poor expression in endometrial cancer cell HEC‐50 derivatives exhibiting high invasive ability,27 implying its close association with tumour invasion. This evidence concerns the gene TMEM161B and endometrial cancer.